Results 181 to 190 of about 298,796 (340)

The purification and properties of phospholipase A from human pancreas [PDF]

open access: green, 1962
Wendy L. Magee   +3 more
openalex   +1 more source

The Site of Attack of Phospholipase (Lecithinase) A on Lecithin: A Re-evaluation

open access: hybrid, 1960
Donald J. Hanahan   +2 more
openalex   +1 more source

Integrating construction and spatial imaging of organoid for tumor metabolic heterogeneity and interactions

open access: yesVIEW, EarlyView.
Enzymatically derived tissue debris (TD) is utilized to establish patient‐derived lung cancer tissue spheres (LCOs), which, in conjunction with mass spectrometry imaging, enable the investigation of tumor metabolic heterogeneity and maintenance of CSCs.
Ling Guo   +6 more
wiley   +1 more source

Intracellular phospholipases A

open access: yesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1980
openaire   +4 more sources

Role of NRP1/HDAC4/CREB/RIPK1 Axis in SARS‐CoV2 S1 Spike Subunit‐Induced Neuronal Toxicity

open access: yesFASEB BioAdvances, EarlyView.
Extracellular SARS‐CoV2 Spike‐S1 protein via NRP1 internalizes in the cytosol of SH‐SY5Y cells. Once inside, it upregulates the epigenetic eraser HDAC4, which binds transcriptional factor CREB, causes RIPK1 up‐regulation, and therefore necroptotic cell death.
Luca Sanguigno   +8 more
wiley   +1 more source

Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine

open access: yesFASEB BioAdvances, EarlyView.
Plasmalogens are specialized lipids affecting the membrane structure, dynamics, and key cell signaling pathways. They protect cells from oxidative damage. Plasmalogen deficiency is associated with severe diseases. Lipid nanoparticles and nanomedicine offer unexplored therapeutic potential for restoring plasmalogen levels under pathological conditions ...
Yu Wu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy